JO1866B1 - Anti-virus agents - Google Patents

Anti-virus agents

Info

Publication number
JO1866B1
JO1866B1 JO19941866A JOP19941866A JO1866B1 JO 1866 B1 JO1866 B1 JO 1866B1 JO 19941866 A JO19941866 A JO 19941866A JO P19941866 A JOP19941866 A JO P19941866A JO 1866 B1 JO1866 B1 JO 1866B1
Authority
JO
Jordan
Prior art keywords
viral agents
riboflavin
derivatives
administration
given
Prior art date
Application number
JO19941866A
Other languages
Arabic (ar)
English (en)
Inventor
اودار ايوكو واشنطن
Original Assignee
رادوباث ليمتد
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by رادوباث ليمتد filed Critical رادوباث ليمتد
Application granted granted Critical
Publication of JO1866B1 publication Critical patent/JO1866B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JO19941866A 1993-10-19 1994-01-19 Anti-virus agents JO1866B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939321558A GB9321558D0 (en) 1993-10-19 1993-10-19 Anti-viral agents

Publications (1)

Publication Number Publication Date
JO1866B1 true JO1866B1 (en) 1995-12-27

Family

ID=10743784

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19941866A JO1866B1 (en) 1993-10-19 1994-01-19 Anti-virus agents

Country Status (26)

Country Link
EP (1) EP0739208A1 (hu)
JP (1) JPH09505804A (hu)
CN (1) CN1140992A (hu)
AP (1) AP620A (hu)
AU (1) AU7943794A (hu)
BG (1) BG100599A (hu)
BR (1) BR9407862A (hu)
CA (2) CA2123825A1 (hu)
CO (1) CO4520283A1 (hu)
CZ (1) CZ113796A3 (hu)
EE (1) EE9600057A (hu)
GB (2) GB9321558D0 (hu)
HR (1) HRP940688A2 (hu)
HU (1) HUT76322A (hu)
IL (1) IL111338A0 (hu)
JO (1) JO1866B1 (hu)
MA (1) MA23356A1 (hu)
MD (1) MD960168A (hu)
NO (1) NO961547L (hu)
OA (1) OA10579A (hu)
PE (1) PE5596A1 (hu)
PL (1) PL314008A1 (hu)
SK (1) SK50696A3 (hu)
UY (1) UY23844A1 (hu)
WO (1) WO1995011028A1 (hu)
ZA (1) ZA948191B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188052A (ja) * 1993-12-27 1995-07-25 Sanwa Kagaku Kenkyusho Co Ltd インターフェロン用作用効果増強剤及び該増強剤とインターフェロンとを含有する抗ウイルス活性増強組成物
US5756479A (en) * 1994-12-29 1998-05-26 Research Development Foundation Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
AU2003299486A1 (en) * 2002-05-10 2004-06-03 The Ohio State University Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
ITTO20020622A1 (it) 2002-07-16 2004-01-16 Dayco Europe Srl Gruppo integrato puleggia-smorzatore torsionale
CN100413866C (zh) * 2002-08-02 2008-08-27 中国人民解放军军事医学科学院放射医学研究所 核黄素衍生物及其制备方法与应用
EP2545788A1 (de) * 2011-07-13 2013-01-16 Martin Hulliger Diätisches Mehrkomponentensystem
JP2018131410A (ja) * 2017-02-15 2018-08-23 ヒノキ新薬株式会社 カスパーゼ−３阻害剤とその用途
CN111565715A (zh) * 2017-10-24 2020-08-21 卢内拉生物技术有限公司 Mitoflavoscin：含靶向黄素的酶通过抑制线粒体呼吸作用消除癌症干细胞(CSCS)
CN114126603A (zh) * 2019-07-09 2022-03-01 帝斯曼知识产权资产管理有限公司 用核黄素或dha降低艾拉弗德的病毒活性

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219545A (en) * 1979-03-23 1980-08-26 Collins Calvin E Treatment of infectious keratoconjunctivitis in animals
US4264601A (en) * 1979-06-12 1981-04-28 The Board Of Regents Of The University Of Oklahoma Antihypertensive agents and their use in treatment of hypertension
US4500524A (en) * 1982-09-15 1985-02-19 Trustees Of Boston University Tranquilizing and reducing or preventing seizures
WO1991002529A2 (en) * 1989-08-14 1991-03-07 John Bennett Kizer Product and method for killing abnormal vertebrate cells
JP2727471B2 (ja) * 1989-09-14 1998-03-11 三井農林株式会社 インフルエンザウィルス感染予防剤
US5192264A (en) * 1989-10-06 1993-03-09 The Beth Israel Hospital Association Methods and apparatus for treating disease states using oxidized lipoproteins
US5217716A (en) * 1990-07-18 1993-06-08 The Beth Israel Hospital Association Method for treating viral infections using oxidized lipoproteins
FR2674753B1 (fr) * 1991-04-02 1995-03-10 Jean Berque Nouvelles indications therapeutiques, en particulier pour le traitement du sida, d'un medicament deja existant et fabrique a partir d'une molecule denuee de contre-indications et d'effets indesirables.
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
WO1993010784A1 (en) * 1991-11-25 1993-06-10 University Of Michigan Therapeutic composition and method for preventing reperfusion injury
JP3073309B2 (ja) * 1992-03-27 2000-08-07 雪印乳業株式会社 シアル酸結合５−デアザフラビン系化合物

Also Published As

Publication number Publication date
GB9321558D0 (en) 1993-12-08
GB9421099D0 (en) 1994-12-07
CA2174552A1 (en) 1995-04-27
BR9407862A (pt) 1997-05-20
OA10579A (en) 2002-06-19
HUT76322A (en) 1997-08-28
WO1995011028A1 (en) 1995-04-27
CO4520283A1 (es) 1997-10-15
PL314008A1 (en) 1996-08-05
CA2123825A1 (en) 1995-04-20
NO961547D0 (no) 1996-04-18
PE5596A1 (es) 1996-04-18
HRP940688A2 (en) 1997-04-30
AU7943794A (en) 1995-05-08
IL111338A0 (en) 1994-12-29
NO961547L (no) 1996-06-19
SK50696A3 (en) 1997-01-08
BG100599A (en) 1997-02-28
CZ113796A3 (en) 1996-11-13
MA23356A1 (fr) 1995-07-01
ZA948191B (en) 1995-06-08
HU9601006D0 (en) 1996-06-28
JPH09505804A (ja) 1997-06-10
EP0739208A1 (en) 1996-10-30
UY23844A1 (es) 1995-03-28
AP620A (en) 1997-10-14
GB2283913A (en) 1995-05-24
CN1140992A (zh) 1997-01-22
EE9600057A (et) 1996-10-15
AP9400695A0 (en) 1995-01-31
MD960168A (ro) 1998-04-30

Similar Documents

Publication Publication Date Title
AU693747B2 (en) Imidazo(4,5-c)pyridin-4-amines
DE69311556D1 (de) Inhalationspulver enthaltend antistatisches hilfsmittel
HU9302063D0 (en) Method for producing optically active 5h-pyrrolo(3,4-b)pyrazine derivatives and one for producing pharmaceutical preparatives containing them as active agent
EP0731712A4 (en) PHYSIOLOGICAL STABILIZED BUTTERIC ACID PREPARATIONS, AND BUTTERIC ACIDS AND DERIVATIVES AS ANTINEOPLASTIC ACTIVE SUBSTANCE
JPS6429362A (en) 3-demethylmevalonic acid derivative
MY109310A (en) Antimicrobial method and formulation employing type ii endoglucosidase and antimicrobial agent
CA2263561A1 (en) Thienopyrimidines
HUT58745A (en) Process for produicng rapamycin derivatives and pharmaceutical compositions containing them as active components
HU9302496D0 (en) Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
ZA945546B (en) Antifugal nail solution
DE3484997D1 (de) Zellstimulierendes mittel.
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
JO1866B1 (en) Anti-virus agents
HU906721D0 (en) Methylene-diphosphonic acid derivatives and inflammation-preventing preparations containing them as active agents
GR3024686T3 (en) Novel guinolone and naphthyridone derivatives.
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
MY115429A (en) Fenbendazole formulations
HU9203579D0 (en) Nematocidal preparatives containing pyrimidine derivatives as active agent and method for producing these active agents
NO931011L (no) 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -estere
EP0314984A3 (de) Verwendung von 2-Pyrimidinyl-1-piperazin-Derivaten
AU7025087A (en) Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base
AU570399B2 (en) Amino and n-substituted (d3) trishomocubanes
ZA939633B (en) Pharmaceutical compounds
HU9203576D0 (en) Nematocidal preparatives containing pyrimidine derivatives as active agent and method for producing these active agents